ロード中...
The potential danger of suboptimal antibody responses in COVID-19
There is a desperate need for effective therapies and vaccines for SARS-CoV-2 to mitigate the growing economic crisis that has ensued from societal lockdown. Vaccines are being developed at an unprecedented speed and are already in clinical trials, without preclinical testing for safety and efficacy...
保存先:
| 出版年: | Nat Rev Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7187142/ https://ncbi.nlm.nih.gov/pubmed/32317716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41577-020-0321-6 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|